Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Aruba Science Wire.
Press releases published on August 13, 2025
X4 Pharmaceuticals Announces Closing of Upsized $85 Million Private Placement
GlobeNewswire
·
August 13, 2025
BOSTON, Aug. 13, 2025 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (Nasdaq: XFOR), a company driven to improve the lives of people with rare diseases of the immune system, today closed an upsized private placement of 11,040,776 shares of common stock and pre- …
RentRedi Makes 2025 Inc. 5000 List for Second Consecutive Year
GlobeNewswire
·
August 13, 2025
NEW YORK, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Inc. announced yesterday that RentRedi, the fastest-growing property management software for smart real estate investors, made its annual Inc. 5000 list, the most prestigious ranking of the fastest-growing …
BiomX Reports Second Quarter 2025 Financial Results and Provides Program Updates
GlobeNewswire
·
August 13, 2025
Positive Phase 2 results for BX211 demonstrated >40% wound size reduction vs. placebo in diabetic foot osteomyelitis patients; Planning underway for potential registrational study Nature Communications publication of new BX004 Phase 1b/2a data demonstrated …
Ocugen, Inc. Announces Positive Scientific Advice from the European Medicines Agency Related to the Approval Pathway for OCU410ST—Modifier Gene Therapy for Stargardt Disease
GlobeNewswire
·
August 13, 2025
MALVERN, Pa., Aug. 13, 2025 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced that the Committee for Medicinal Products for Human Use (CHMP) …
Global-e Reports Second Quarter 2025 Results
GlobeNewswire
·
August 13, 2025
PETAH-TIKVA, Israel, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Global-e Online Ltd. (Nasdaq: GLBE) the platform powering global direct-to-consumer e-commerce, today reported financial results for the second quarter of 2025. “We had another strong quarter, meeting …
Neuronascent Announces Progress for Lead Candidate NNI-362: Publication of Phase 1a Clinical Trial Results and FDA Grants Waiver of Fee for Canine Cognitive Disorder 2025 Submissions
GlobeNewswire
·
August 13, 2025
BALTIMORE., Aug. 13, 2025 (GLOBE NEWSWIRE) -- Neuronascent Inc., a privately-held neuron regeneration therapeutics company, today announced that the Phase 1a trial in aged human subjects of its NNI-362 therapy was published in Alzheimer’s Research and …
Instil Bio Reports Second Quarter 2025 Financial Results and Provides Corporate Update
GlobeNewswire
·
August 13, 2025
With the clearance of the U.S. IND, initiation of the U.S. clinical trial of AXN-2510/IMM2510 (“‘2510”) anticipated before the end of 2025 Updated ‘2510 monotherapy data in squamous-NSCLC to be presented at IASLC’s 2025 World Conference on Lung Cancer ( …
Scilex Holding Company (Nasdaq: SCLX) Announces Effectiveness of Registration Statement on Form S-4 for the Proposed Business Combination of Denali Capital Acquisition Corp. and Semnur Pharmaceuticals, Inc., a Majority-Owned Subsidiary of Scilex
GlobeNewswire
·
August 13, 2025
Denali’s registration statement on Form S-4 declared effective by the Securities and Exchange Commission Extraordinary general meeting of Denali Capital Acquisition Corp. shareholders to approve the proposed business combination is scheduled to be held on …
Greenwich LifeSciences Announces Expansion of Flamingo-01 into Romania
GlobeNewswire
·
August 13, 2025
STAFFORD, Texas, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01, which is evaluating GLSI-100, an immunotherapy …
Aerospike’s New Expression Indexes Simplify Developer Code and Reduce Memory Overhead for Application and AI Queries
GlobeNewswire
·
August 13, 2025
MOUNTAIN VIEW, Calif., Aug. 13, 2025 (GLOBE NEWSWIRE) -- Aerospike, Inc., today unveiled new expression indexes that boost query performance while significantly reducing memory use and operational costs for machine learning and generative and agentic AI. …
Aurora Mobile to Report Second Quarter 2025 Financial Results on August 28, 2025
GlobeNewswire
·
August 13, 2025
SHENZHEN, China, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Aurora Mobile Limited (NASDAQ: JG) (“Aurora Mobile” or the “Company”), a leading provider of customer engagement and marketing technology services in China, today announced that it will release its …
MoonFox Data | Li Auto Financial Report Analysis: Pure Electric SUV Model i8 to become the Key Breakthrough in 2025
GlobeNewswire
·
August 13, 2025
Shenzhen, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Shenzhen, Aug 12, 2025 (GLOBE NEWSWIRE) - Currently, automakers are accelerating model upgrades, with new vehicles becoming larger, more intelligent, and offering extended range. Li Auto's relatively limited …
Atos nommé leader des solutions et services de cybersécurité dans le rapport ISG Provider Lens pour l’Allemagne
GlobeNewswire
·
August 13, 2025
News Atos nommé leader des solutions et services de cybersécurité dans le rapport ISG Provider Lens pour l’Allemagne Paris, France – 13 août 2025 – Atos annonce aujourd'hui avoir été nommé …
Atos named a Leader in ISG Provider Lens for Cybersecurity – Services and Solutions in Germany
GlobeNewswire
·
August 13, 2025
News Atos named a Leader in ISG Provider Lens for Cybersecurity – Services and Solutions in Germany Paris, France – August 13, 2025 – Atos today announces it has been named a Leader by …
UCLOUDLINK GROUP INC. Announces Unaudited Second Quarter 2025 Financial Results
GlobeNewswire
·
August 13, 2025
HONG KONG, Aug. 13, 2025 (GLOBE NEWSWIRE) -- UCLOUDLINK GROUP INC. (“UCLOUDLINK” or the “Company”) (NASDAQ: UCL), the world’s first and leading mobile data traffic sharing marketplace, today announced its unaudited financial results for the three months …
Inworld Runtime: The first AI runtime for consumer applications
GlobeNewswire
·
August 13, 2025
MOUNTAIN VIEW, Calif., Aug. 13, 2025 (GLOBE NEWSWIRE) -- Today Inworld AI released Inworld Runtime - the first AI runtime engineered to scale consumer applications. It lets developers go from prototype to production faster and supports user growth from 10 …
XVR Simulation revolutioniert das Training von Einsatzkräften mit immersiven VR-Lösungen in Deutschland, die Schweiz und Österreich
GlobeNewswire
·
August 13, 2025
DELFT, Die Niederlande, Aug. 13, 2025 (GLOBE NEWSWIRE) -- XVR Simulation B.V., ein weltweit führender Anbieter von Virtual-Reality-Trainingssoftware, kündigt heute seinen verstärkten Fokus auf die Unterstützung von Einsatzkräften in Deutschland, der …
XVR Simulation Revolutionises Emergency Service Training with Immersive VR Solutions for Germany, Switzerland, and Austria
GlobeNewswire
·
August 13, 2025
DELFT, The Netherlands, Aug. 13, 2025 (GLOBE NEWSWIRE) -- XVR Simulation B.V., a global leader in virtual reality (VR) training software, today announced its intensified focus on empowering emergency services across Germany, Switzerland, and Austria with …
Greywolf Therapeutics begins dosing of the first treatment to target the antigenic source of autoimmunity
GlobeNewswire
·
August 13, 2025
This is the first ever autoimmunity study to evaluate a potential functional cure that targets the antigenic source – the origin of autoimmune disease The Phase 1/2 study (up to 141 participants) will evaluate the safety, tolerability and efficacy of …
Santhera schließt Vereinbarung mit GEN über den Vertrieb von AGAMREE® (Vamorolon) in der Türkei
GlobeNewswire
·
August 13, 2025
Pratteln, Schweiz, 13. August 2025 – Santhera Pharmaceuticals (SIX: SANN) gibt die Unterzeichnung einer exklusiven Vereinbarung mit Gen İlaç ve Sağlık Ürünleri San. ve Tic. A.Ş. (GEN) über den Vertrieb und die Vermarktung von AGAMREE® (Vamorolon) in der …